Skip to main content

Carlsmed, Inc.

CARL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001794546

In the last 90 days, Carlsmed, Inc. insiders filed 1 open-market purchase and 1 sale; 74 institutions reported holding it in 13F filings for Q2 2026, worth $59.3M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Carlsmed, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CARL: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders66274+10
Shares5.30M1.23M5.72M+1.64M (+40.3%)
Value$48.0M$11.1M$59.3M+$22.4M (+60.9%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Carlsmed, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CARL in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC1,251,616$13.0M0.01%
Pier Capital, LLC373,677$3.88M0.51%
Millennium Management LLC295,907$3.07M0.00%
Palumbo Wealth Management LLC267,298$2.77M0.59%
AQR Capital Management LLC92,159$956.6K0.00%
D. E. Shaw & Co., Inc.60,439$627.4K0.00%
Bridgeway Capital Management, LLC25,000$259.5K0.00%
Marshall Wace, LLP21,283$220.9K0.00%
Jump Financial, LLC19,414$201.5K0.00%
Two Sigma Investments, LP18,008$186.9K0.00%
Alpine Woods Capital Investors, LLC15,542$161.3K0.04%
Arrowstreet Capital, Limited Partnership14,040$145.7K0.00%
Janney Montgomery Scott LLC13,025$135.0K0.00%
Zevenbergen Capital Investments LLC11,900$123.5K0.00%
Trexquant Investment LP11,001$114.2K0.00%
Armstrong Advisory Group, Inc1,234$12.8K0.00%
SRS Capital Advisors, Inc.749$7.78K0.00%
EverSource Wealth Advisors, LLC207$2.15K0.00%
Fortitude Family Office, LLC30$3110.00%
Rothschild Investment LLC24$2490.00%
SJS Investment Consulting Inc.19$1980.00%
Clearstead Advisors, LLC5$530.00%
JPL Wealth Management, LLC1$110.00%

Sold out (13)

Institutions that held Carlsmed, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CARL in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
OrbiMed Advisors LLC1,252,600$11.3M
Burkehill Global Management, LP50,000$452.5K
Wesbanco Bank Inc37,000$334.9K
XTX Topco Ltd24,738$223.9K
TD Waterhouse Canada Inc.20,000$192.0K
Quadrature Capital Ltd13,352$120.8K
HRT Financial LP12,337$111.0K
Renaissance Technologies LLC10,400$94.1K
GAMMA Investing LLC135$1.22K
Sunrise Financial Services, LLC26$235
Root Financial Partners, LLC15$136
MAI Capital Management4$37
Advisory Services Network, LLC3$27

Not filed for Q2 2026 yet (2)

Institutions that held Carlsmed, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CARL in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC1,227,452$11.1M
CWM, LLC59$534